In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vanessa Elharrar PPD, VP, Vaccines Business Strategy Lead, at PPD Vaccine Clinical Development and Medical Affairs.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vanessa, covering:
Being at the centre of vaccine development and patient distribution over the last year. And the global pandemic’s role as a day of reckoning for the sector to do things differently in terms of virtualisation of trials becoming the norm.
How MRNA vaccines could be the key to helping in HIV research and supporting patients at risk of AIDS.
Carving a career path aimed at making the biggest impact on the global patient population.
The need to be better prepared for future pandemics in terms of better better disease surveillance and detection, but also stockpiling vital equipment and having local vaccine manufacturing capability.
The increasing trend towards CDMOs and CROs merging to offer a complementary and unified offering to help clients reduce timelines.
An MD/Doctor by trade, Vanessa now leads early engagement with Vaccine sponsors and offers strategic guidance in the development and implementation of vaccine trials. Her areas of expertise include COVID-19 vaccine development and medical monitoring of vaccine studies and HIV biomedical prevention. She is Board Certified in Preventive Medicine and Public Health having completed a Masters in Public Health at The John Hopkins University. If that was not impressive enough, Vanessa is also fluent in French, Spanish and Hebrew.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.